Form4insider filings, from the source

Insider holders · CIK 0001566373

Spring Bank Pharmaceuticals, Inc. · SBPH

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Oncology Impact Fund (Cayman) Management L.P.10% Owner—833,839833,839Feb 6, 2018 · 4:11 pm ESTForm 3
MPM Oncology Impact Management GP LLC10% Owner—833,839833,839Feb 6, 2018 · 4:11 pm ESTForm 3
UBS Oncology Impact Fund L.P.10% Owner—833,839833,839Feb 6, 2018 · 4:11 pm ESTForm 3
MPM Oncology Impact Management LP10% Owner—833,839833,839Feb 6, 2018 · 4:11 pm ESTForm 3
Kurt M EichlerDirector589,2731,200590,473Jan 3, 2019 · 4:34 pm ESTForm 4
Radhakrishnan P. IyerChief Scientific Officer431,25050,000481,250May 5, 2016 · 9:41 pm EDTForm 3
Jonathan BatesDirector—141,756141,756May 5, 2016 · 9:38 pm EDTForm 3
Martin J DriscollPresident and CEO60,400—60,400Aug 13, 2018 · 4:04 pm EDTForm 4
Christiana BardonDirector2,29654,82457,120Oct 3, 2018 · 4:25 pm EDTForm 4
Nezam H. AfdhalChief Medical Officer53,300—53,300Nov 23, 2016 · 4:01 pm ESTForm 4
David ArkowitzDirector19,386—19,386Aug 7, 2017 · 4:02 pm EDTForm 4
Todd C BradyDirector13,094—13,094Jan 3, 2018 · 4:12 pm ESTForm 4
Jonathan FreveCFO, Treasurer & Secretary7,482—7,482Nov 23, 2016 · 4:02 pm ESTForm 4
Timothy P ClacksonDirector2,615—2,615Jan 3, 2019 · 4:32 pm ESTForm 4
Scott Andrew SmithDirector0—0Aug 17, 2018 · 4:46 pm EDTForm 3

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.